WallStreetZenWallStreetZen

NASDAQ: TSVT
2seventy Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TSVT

Based on 2 analysts offering 12 month price targets for 2seventy Bio Inc

Min Forecast
$5.00+0.4%
Avg Forecast
$5.00+0.4%
Max Forecast
$5.00+0.4%

Should I buy or sell TSVT stock?

Based on 2 analysts offering ratings for 2seventy Bio Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TSVT stock forecasts and price targets.

TSVT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-14
lockedlocked$00.00+00.00%2025-03-11

1 of 1

Forecast return on equity

Is TSVT forecast to generate an efficient return?

Company
16.39%
Industry
147.71%
Market
81.76%
TSVT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TSVT forecast to generate an efficient return on assets?

Company
7.2%
Industry
35.52%
TSVT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TSVT earnings per share forecast

What is TSVT's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.22
Avg 2 year Forecast
$0.21
Avg 3 year Forecast
$0.53

TSVT revenue forecast

What is TSVT's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$76.4M+101.78%
Avg 2 year Forecast
$84.8M+124%
Avg 3 year Forecast
$81.0M+113.86%
TSVT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TSVT revenue growth forecast

How is TSVT forecast to perform vs Biotechnology companies and vs the US market?

Company
31.23%
Industry
65.42%
Market
10.4%
TSVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TSVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TSVT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TSVT$4.98$5.00+0.40%Hold
HUMA$1.68$19.00+1,030.95%Strong Buy
SEPN$5.90$33.00+459.32%Strong Buy
LSB$1.38N/AN/A
MBX$7.62$41.00+438.06%Strong Buy
View Top Biotech Stocks

2seventy Bio Stock Forecast FAQ

Is 2seventy Bio Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: TSVT) stock is to Hold TSVT stock.

Out of 2 analysts, 0 (0%) are recommending TSVT as a Strong Buy, 0 (0%) are recommending TSVT as a Buy, 2 (100%) are recommending TSVT as a Hold, 0 (0%) are recommending TSVT as a Sell, and 0 (0%) are recommending TSVT as a Strong Sell.

If you're new to stock investing, here's how to buy 2seventy Bio stock.

What is TSVT's earnings growth forecast for 2025-2027?

(NASDAQ: TSVT) 2seventy Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.2%.

2seventy Bio's earnings in 2025 is -$57,247,000.On average, 2 Wall Street analysts forecast TSVT's earnings for 2025 to be -$11,514,444, with the lowest TSVT earnings forecast at -$12,037,828, and the highest TSVT earnings forecast at -$10,991,060. On average, 2 Wall Street analysts forecast TSVT's earnings for 2026 to be $10,729,369, with the lowest TSVT earnings forecast at $6,280,606, and the highest TSVT earnings forecast at $15,178,131.

In 2027, TSVT is forecast to generate $27,739,343 in earnings, with the lowest earnings forecast at $27,739,343 and the highest earnings forecast at $27,739,343.

What is TSVT's revenue growth forecast for 2025-2027?

(NASDAQ: TSVT) 2seventy Bio's forecast annual revenue growth rate of 31.23% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.42%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.4%.

2seventy Bio's revenue in 2025 is $37,862,000.On average, 3 Wall Street analysts forecast TSVT's revenue for 2025 to be $3,998,600,123, with the lowest TSVT revenue forecast at $3,313,019,644, and the highest TSVT revenue forecast at $4,705,115,955. On average, 3 Wall Street analysts forecast TSVT's revenue for 2026 to be $4,438,818,262, with the lowest TSVT revenue forecast at $3,592,506,609, and the highest TSVT revenue forecast at $5,447,954,625.

In 2027, TSVT is forecast to generate $4,237,838,872 in revenue, with the lowest revenue forecast at $4,237,838,872 and the highest revenue forecast at $4,237,838,872.

What is TSVT's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: TSVT) forecast ROA is 7.2%, which is lower than the forecast US Biotechnology industry average of 35.52%.

What is TSVT's Price Target?

According to 2 Wall Street analysts that have issued a 1 year TSVT price target, the average TSVT price target is $5.00, with the highest TSVT stock price forecast at $5.00 and the lowest TSVT stock price forecast at $5.00.

On average, Wall Street analysts predict that 2seventy Bio's share price could reach $5.00 by Mar 14, 2026. The average 2seventy Bio stock price prediction forecasts a potential upside of 0.4% from the current TSVT share price of $4.98.

What is TSVT's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: TSVT) 2seventy Bio's current Earnings Per Share (EPS) is -$1.10. On average, analysts forecast that TSVT's EPS will be -$0.22 for 2025, with the lowest EPS forecast at -$0.23, and the highest EPS forecast at -$0.21. On average, analysts forecast that TSVT's EPS will be $0.21 for 2026, with the lowest EPS forecast at $0.12, and the highest EPS forecast at $0.29. In 2027, TSVT's EPS is forecast to hit $0.53 (min: $0.53, max: $0.53).

What is TSVT's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: TSVT) forecast ROE is 16.39%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.